123 related articles for article (PubMed ID: 3495696)
1. Intralymphatic interleukin-2 treatment of a hemophiliac AIDS patient with defective interleukin-2 production.
Gramatzki M; Burmester GR; Heyder N; Nüsslein HG; Rödl W; Grote W; Monner DA; Mühlradt PF; Kalden JR
Klin Wochenschr; 1987 Apr; 65(8):380-6. PubMed ID: 3495696
[TBL] [Abstract][Full Text] [Related]
2. Intralymphatic interleukin 2 treatment in patients with acquired immunodeficiency syndrome: preliminary experience in three cases.
Gramatzki M; Nüsslein H; Burmester GR; Rödl W; Heyder N; Grote W; Monner DA; Mühlradt PF; Kalden JR
Immunobiology; 1986 Sep; 172(3-5):438-47. PubMed ID: 3100436
[TBL] [Abstract][Full Text] [Related]
3. Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC).
Ernst M; Kern P; Flad HD; Ulmer AJ
J Clin Immunol; 1986 Mar; 6(2):170-81. PubMed ID: 2940258
[TBL] [Abstract][Full Text] [Related]
4. Treatment of immunodeficiency with interleukin-2: initial exploration.
Mertelsmann R; Welte K; Sternberg C; O'Reilly R; Moore MA; Clarkson BD; Oettgen HF
J Biol Response Mod; 1984 Oct; 3(5):483-90. PubMed ID: 6334136
[TBL] [Abstract][Full Text] [Related]
5. [In vitro and in vivo studies with interleukin 2 (IL-2) and various immunostimulants in a patient with AIDS].
Vaith P; Maas D; Feigl D; Hauke G; Lang B; Oepke G; Stierle HE; Bross KJ; Andreesen R; Gross G
Immun Infekt; 1985 Apr; 13(2):51-63. PubMed ID: 2581885
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 and interleukin 2 production in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex.
Gupta S; Vayuvegula B; Ruhling M; Thornton M
J Clin Lab Immunol; 1987 Mar; 22(3):113-6. PubMed ID: 3112400
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndrome.
Chachoua A; Green MD; Valentine F; Muggia FM
Cancer Invest; 1989; 7(3):225-9. PubMed ID: 2790539
[TBL] [Abstract][Full Text] [Related]
8. IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome.
Reuben JM; Hersh EM; Murray JL; Munn CG; Mehta SR; Mansell PW
Lymphokine Res; 1985; 4(2):103-16. PubMed ID: 2987624
[TBL] [Abstract][Full Text] [Related]
9. Abnormal lymphocyte response to exogenous interleukin-2 in homosexuals with acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC).
Murray JL; Hersh EM; Reuben JM; Munn CG; Mansell PW
Clin Exp Immunol; 1985 Apr; 60(1):25-30. PubMed ID: 3924451
[TBL] [Abstract][Full Text] [Related]
10. [Intensive care problems in AIDS patients].
Lode H; Höffken G; Dissmann T; Schäfer H
Pneumologie; 1990 Feb; 44 Suppl 1():407-8. PubMed ID: 2367423
[TBL] [Abstract][Full Text] [Related]
11. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS.
Lifson JD; Benike CJ; Mark DF; Koths K; Engleman EG
Lancet; 1984 Mar; 1(8379):698-702. PubMed ID: 6143040
[TBL] [Abstract][Full Text] [Related]
13. Acquired immunodeficiency syndrome, Pneumocystis carinii pneumonia, and the danger of prognostication: apples to apples.
Peruzzi WT
Crit Care Med; 1999 Jun; 27(6):1043-4. PubMed ID: 10397194
[No Abstract] [Full Text] [Related]
14. Unusual remission of Pneumocystis carinii pneumonia in a patient with the acquired immune deficiency syndrome.
Hurley P; Weikel C; Temeles D; Rosenberg S; Pearson R
Am J Med; 1987 Mar; 82(3 Spec No):645-8. PubMed ID: 3493693
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
Bonavida B; Katz J; Gottlieb M
J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches to patients with AIDS.
Lane HC; Masur H; Gelmann EP; Fauci AS
Cancer Res; 1985 Sep; 45(9 Suppl):4674s-4676s. PubMed ID: 2990706
[TBL] [Abstract][Full Text] [Related]
17. Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy.
Imami N; Hardy GA; Nelson MR; Morris-Jones S; Al-Shahi R; Antonopoulos C; Gazzard B; Gotch FM
Clin Exp Immunol; 1999 Oct; 118(1):78-86. PubMed ID: 10540163
[TBL] [Abstract][Full Text] [Related]
18. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
Prince HE; Kermani-Arab V; Fahey JL
J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 production and response to exogenous interleukin-2 in a patient with the acquired immune deficiency syndrome (AIDS).
Hauser GJ; Bino T; Rosenberg H; Zakuth V; Geller E; Spirer Z
Clin Exp Immunol; 1984 Apr; 56(1):14-7. PubMed ID: 6609030
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
